Eric P. Brass

9.5k total citations · 2 hit papers
156 papers, 7.2k citations indexed

About

Eric P. Brass is a scholar working on Clinical Biochemistry, Molecular Biology and Surgery. According to data from OpenAlex, Eric P. Brass has authored 156 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Clinical Biochemistry, 46 papers in Molecular Biology and 39 papers in Surgery. Recurrent topics in Eric P. Brass's work include Metabolism and Genetic Disorders (50 papers), Peripheral Artery Disease Management (32 papers) and Mitochondrial Function and Pathology (21 papers). Eric P. Brass is often cited by papers focused on Metabolism and Genetic Disorders (50 papers), Peripheral Artery Disease Management (32 papers) and Mitochondrial Function and Pathology (21 papers). Eric P. Brass collaborates with scholars based in United States, United Kingdom and Canada. Eric P. Brass's co-authors include William R. Hiatt, Charles L. Hoppel, Judith G. Regensteiner, Eugene E. Wolfel, Brad Spellberg, William R. Hiatt, John E. Edwards, Loren G. Miller, John H. Powers and Antonino Amato and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.

In The Last Decade

Eric P. Brass

156 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trends in Antimicrobial Drug Development: Implications for the Future

2004 633 citations Brad Spellberg, Eric P. Brass et al. profile →
Benefit of exercise conditioning for patients with peripheral arterial disease.

1990 383 citations William R. Hiatt, Judith G. Regensteiner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric P. Brass United States	47	2.3k	1.9k	1.4k	1.1k	920	156	7.2k
Maria F. Lopes‐Virella United States	54	2.4k 1.0×	2.1k 1.1×	1.1k 0.7×	1.1k 1.0×	564 0.6×	225	10.7k
Robert L. Danner United States	52	1.5k 0.7×	2.3k 1.2×	676 0.5×	1.3k 1.1×	1.2k 1.4×	193	12.2k
Jordi Camps Spain	46	1.2k 0.5×	1.4k 0.8×	2.0k 1.4×	628 0.6×	346 0.4×	252	7.1k
Edgard Delvin Canada	50	1.2k 0.5×	1.4k 0.8×	524 0.4×	939 0.8×	391 0.4×	157	6.4k
Walter H. Hörl Austria	61	2.4k 1.0×	2.2k 1.1×	556 0.4×	1.2k 1.0×	1.5k 1.6×	393	13.4k
Robert A. Branch United States	52	806 0.3×	1.4k 0.8×	444 0.3×	785 0.7×	930 1.0×	252	9.6k
Peter Nilsson‐Ehle Sweden	48	2.1k 0.9×	1.8k 0.9×	388 0.3×	1.6k 1.4×	458 0.5×	246	9.5k
Sydney Tang Hong Kong	51	1.1k 0.5×	2.0k 1.1×	578 0.4×	649 0.6×	944 1.0×	314	9.4k
Murray L. Barclay New Zealand	50	1.9k 0.8×	1.7k 0.9×	362 0.3×	520 0.5×	476 0.5×	197	9.0k
Philip W. Connelly Canada	64	3.5k 1.5×	2.0k 1.1×	1.1k 0.8×	2.0k 1.7×	308 0.3×	289	13.7k

Countries citing papers authored by Eric P. Brass

Since Specialization

Citations

This map shows the geographic impact of Eric P. Brass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric P. Brass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric P. Brass more than expected).

Fields of papers citing papers by Eric P. Brass

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric P. Brass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric P. Brass. The network helps show where Eric P. Brass may publish in the future.

Co-authorship network of co-authors of Eric P. Brass

This figure shows the co-authorship network connecting the top 25 collaborators of Eric P. Brass. A scholar is included among the top collaborators of Eric P. Brass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric P. Brass. Eric P. Brass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laurora, Irene, et al.. (2022). Modeling the potential benefit of an over-the-counter progestin-only pill in preventing unintended pregnancies in the U.S.. Contraception. 117. 7–12. 9 indexed citations

Spellberg, Brad, Ashraf S. Ibrahim, Peter Chin‐Hong, et al.. (2011). The Deferasirox–AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. Journal of Antimicrobial Chemotherapy. 67(3). 715–722. 219 indexed citations

Catlin, Jesse R., Cornelia Pechmann, & Eric P. Brass. (2011). The Influence of Need for Cognition and Principal Display Panel Factors on Over-the-Counter Drug Facts Label Comprehension. Health Communication. 27(3). 264–272. 10 indexed citations

Brass, Eric P., Leslie T. Cooper, Roger Morgan, & William R. Hiatt. (2011). A phase II dose-ranging study of the phosphodiesterase inhibitor K-134 in patients with peripheral artery disease and claudication. Journal of Vascular Surgery. 55(2). 381–389.e1. 15 indexed citations

Lewis, Roger, Jason T. Connor, John R. Teerlink, et al.. (2011). Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication. Trials. 12(1). 134–134. 6 indexed citations

Brass, Eric P., et al.. (2008). Can Consumers Self-Select for Appropriate Use of an Over-the-Counter Statin? The Self Evaluation of Lovastatin to Enhance Cholesterol Treatment Study. The American Journal of Cardiology. 101(10). 1448–1455. 7 indexed citations

Nehler, Mark R., Eric P. Brass, Richard Anthony, et al.. (2007). Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes. Journal of Vascular Surgery. 45(5). 953–961. 37 indexed citations

Brass, Eric P., Richard Anthony, John Dormandy, et al.. (2006). Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. Journal of Vascular Surgery. 43(4). 752–759. 85 indexed citations

Brass, Eric P., et al.. (2004). Differential management of cardiovascular disease in ESRD by nephrologists and cardiologists. American Journal of Kidney Diseases. 44(2). 309–321. 4 indexed citations

10.

Brass, Eric P.. (2003). Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil. Clinical Pharmacology & Therapeutics. 73(4). 338–347. 34 indexed citations

11.

Brass, Eric P.. (2003). Label development and the label comprehension study for over-the-counter drugs. Clinical Pharmacology & Therapeutics. 74(5). 406–412. 24 indexed citations

12.

Brass, Eric P.. (2002). Pivalate-Generating Prodrugs and Carnitine Homeostasis in Man. Pharmacological Reviews. 54(4). 589–598. 105 indexed citations

13.

Sietsema, Kathy E., William R. Hiatt, Anne Esler, et al.. (2002). Clinical and demographic predictors of exercise capacity in end-stage renal disease. American Journal of Kidney Diseases. 39(1). 76–85. 75 indexed citations

14.

Brass, Eric P.. (2001). Changing the Status of Drugs from Prescription to Over-the-Counter Availability. New England Journal of Medicine. 345(11). 810–816. 126 indexed citations

15.

Brass, Eric P., et al.. (2001). Intravenous l-carnitine increases plasma carnitine, reducesfatigue, and may preserve exercise capacity in hemodialysis patients. American Journal of Kidney Diseases. 37(5). 1018–1028. 79 indexed citations

16.

Wang, Hong, William R. Hiatt, Thomas J. Barstow, & Eric P. Brass. (1999). Relationships between muscle mitochondrial DNA content, mitochondrial enzyme activity and oxidative capacity in man: alterations with disease. PubMed. 80(1). 22–27. 90 indexed citations

17.

Brass, Eric P. & William R. Hiatt. (1998). The Role of Carnitine and Carnitine Supplementation During Exercise in Man and in Individuals with Special Needs. Journal of the American College of Nutrition. 17(3). 207–215. 41 indexed citations

18.

Brass, Eric P.. (1993). Hydroxycobalamin[c-lactam] Increases Total Coenzyme A Content in Primary Culture Hepatocytes by Accelerating Coenzyme A Biosynthesis Secondary to Acyl-CoA Accumulation. Journal of Nutrition. 123(11). 1801–1807. 3 indexed citations

19.

Krähenbühl, Stephan, et al.. (1990). Increased hepatic mitochondrial capacity in rats with hydroxy-cobalamin[c-lactam]-induced methylmalonic aciduria.. Journal of Clinical Investigation. 86(6). 2054–2061. 22 indexed citations

20.

Hiatt, William R., Judith G. Regensteiner, Eugene E. Wolfel, Laura J. Ruff, & Eric P. Brass. (1989). Carnitine and acylcarnitine metabolism during exercise in humans. Dependence on skeletal muscle metabolic state.. Journal of Clinical Investigation. 84(4). 1167–1173. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact